Cancer antigen 549 tests

Recombinant protein fragment of Human CA9 with N-terminal His6ABP (ABP = Albumin Binding Protein derived from Streptococcal Protein G) fusion tag. Application Suitable as a blocking agent using corresponding antibodies.

Recombinant protein fragment of Human CAPN9 with N-terminal His6ABP (ABP = Albumin Binding Protein derived from Streptococcal Protein G) fusion tag. Application Suitable as a blocking agent using corresponding antibodies.

N-terminal His 6 ABP (ABP = Albumin Binding Protein derived from Streptococcal Protein G) Application Suitable as a blocking agent and positive assay control using corresponding antibodies. Linkage Corresponding Antibodies HPA062050 Physical form

Recombinant protein fragment of Human CASP9 with N-terminal His6ABP (ABP = Albumin Binding Protein derived from Streptococcal Protein G) fusion tag. Application Suitable as a blocking agent using corresponding antibodies.

PrEST Antigen CD69 CD69 molecule, 100ul UN 1687 6.1 PG2

Recombinant protein fragment of Human CD96 with N-terminal His6ABP (ABP = Albumin Binding Protein derived from Streptococcal Protein G) fusion tag. Application Suitable as a blocking agent using corresponding antibodies.

PrEST Antigen CD96 CD96 molecule, 100ul UN 1687 6.1 PG2

Recombinant protein fragment of Human CDH9 with N-terminal His6ABP (ABP = Albumin Binding Protein derived from Streptococcal Protein G) fusion tag. Application Suitable as a blocking agent using corresponding antibodies.

PrEST Antigen CDK9 cyclin-dependent kinase 9, 100ul UN 1687

Recombinant protein fragment of Human CEP104 with N-terminal His6ABP (ABP = Albumin Binding Protein derived from Streptococcal Protein G) fusion tag. Application Suitable as a blocking agent using corresponding antibodies.

PrEST Antigen CEP295NL CEP295 N-terminal like, 100ul UN 1687

Recombinant protein fragment of Human CEP350&nbspwith&nbspN-terminal His 6 ABP (ABP = Albumin Binding Protein derived from Streptococcal Protein G) fusion tag.&nbsp &nbsp&nbsp Application Blocking agent and positive assay control using